Lv51
1108 积分 2022-07-26 加入
Designing time-limited aryl hydrocarbon receptor drugs: A kinetic framework from the FICZ–CYP1A1 feedback axis
3天前
已完结
Human retinal organoids: from developmental biology to translational applications
1个月前
已完结
Retinal organoids in disease modeling and drug discovery: Opportunities and challenges
1个月前
已完结
Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential
1个月前
已完结
Pharmacokinetics of major indigo naturalis indole alkaloids in humans and their association with systemic aryl hydrocarbon receptor activity
1个月前
已完结
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia
1个月前
已完结
Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population
1个月前
已完结
Impact of UDP-Glucuronosyltransferase 1A Haplotypes on Irinotecan Treatment
1个月前
已完结
Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): Mechanisms responsible for interindividual variation of UGT levels
1个月前
已完结
皖公网安备34019202002308
